Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus

Nutrition Research Reviews

Volumn 23, Issue 2, 2010, Pages 230-246

  Kubo, Ai ^a   Corley, Douglas A ^a,b   Jensen, Christopher D ^a   Kaur, Rubinder ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Barrett's oesophagus; Dietary factors; Oesophageal adenocarcinoma

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CARBOHYDRATE; FAT; FOLIC ACID; HETEROCYCLIC AMINE; IRON; NITRATE; NITRITE; SELENIUM;

ARTICLE; BARRETT ESOPHAGUS; CANCER PREVENTION; CANCER RISK; DIETARY INTAKE; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; FIBER; FOOD INTAKE; HUMAN; VITAMIN SUPPLEMENTATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DIET; DIETARY FIBER; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FRUIT; HUMANS; MICRONUTRIENTS; RISK FACTORS; VEGETABLES;

EID: 78650534682     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422410000132     Document Type: Article

References (119)

1. Blot WJ, Devesa SS, Fraumeni JF Jr (1993) Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 270, 1320.
2. Blot WJ, Devesa SS, Kneller RW, et al. (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265, 1287-1289.
3. Blot WJ, McLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26, Suppl. 5, 2-8.
4. Kubo A, Corley DA (2002) Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 95, 2096-2102. (Pubitemid 35253370)
5. Daly JM, Karnell LH, Menck HR (1996) National Cancer Data Base report on esophageal carcinoma. Cancer 78, 1820-1828. (Pubitemid 26330913)
6. Winters C Jr, Spurling TJ, Chobanian SJ, et al. (1987) Barretts esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92, 118-124. (Pubitemid 17207669)
7. Falk GW (2009) Risk factors for esophageal cancer development. Surg Oncol Clin N Am 18, 469-485.
8. Kubo A, Corley DA (2004) Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99, 582-588. (Pubitemid 38607957)
9. Falk GW, Thota PN, Richter JE, et al. (2005) Barretts esophagus in women: demographic features and progression to high-grade dysplasia and cancer. Clin Gastroenterol Hepatol 3, 1089-1094.
10. Ronkainen J, Aro P, Storskrubb T, et al. (2005) Prevalence of Barretts esophagus in the general population: an endoscopic study. Gastroenterology 129, 1825-1831. (Pubitemid 41772961)
11. van Soest EM, Siersema PD, Dieleman JP, et al. (2005) Age and sex distribution of the incidence of Barretts esophagus found in a Dutch primary care population. Am J Gastroenterol 100, 2599-2600. (Pubitemid 43919700)
12. van Blankenstein M, Looman CW, Johnston BJ, et al. (2005) Age and sex distribution of the prevalence of Barretts esophagus found in a primary referral endoscopy center. Am J Gastroenterol 100, 568-576. (Pubitemid 40487554)
13. Johnston MH, Hammond AS, Laskin W, et al. (1996) The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 91, 1507-1511. (Pubitemid 26269160)
14. Spechler SJ (2002) Clinical practice. Barretts esophagus. N Engl J Med 346, 836-842.
15. Wong A, Fitzgerald RC (2005) Epidemiologic risk factors for Barretts esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 3, 1-10. (Pubitemid 40092937)
16. Kamangar F, Chow WH, Abnet CC, et al. (2009) Environmental causes of esophageal cancer. Gastroenterol Clin North Am 38, 27-57, vii.
17. Corley DA, Kubo A, Zhao W (2008) Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 17, 352-358. (Pubitemid 351272786)
18. Wang Y, Beydoun MA (2007) The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29, 6-28. (Pubitemid 47229643)
19. Giovino GA (2007) The tobacco epidemic in the United States. Am J Prev Med 33, Suppl. 6, S318-S326.
20. Cokkinides V, Bandi P, McMahon C, et al. (2009) Tobacco control in the United States - recent progress and opportunities. CA Cancer J Clin 59, 352-365.
21. World Cancer Research Fund, American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: World Cancer Research Fund.
22. Clarkson PM, Thompson HS (2000) Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr 72, Suppl. 2, 637S-646S. (Pubitemid 30650064)
23. Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44, 239-267.
24. Wetscher GJ, Hinder RA, Bagchi D, et al. (1995) Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 170, 552-557.
25. Wetscher GJ, Hinder PR, Bagchi D, et al. (1995) Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 40, 1292-1296.
26. Chen X, Ding YW, Yang G, et al. (2000) Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 21, 257-263. (Pubitemid 30098711)
27. Hao J, Zhang B, Liu B, et al. (2009) Effect of a-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model. Int J Cancer 124, 1270-1275.
28. Chen H, Tucker KL, Graubard BI, et al. (2002) Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer 42, 33-40. (Pubitemid 35007004)
29. Mayne ST, Risch HA, Dubrow R, et al. (2001) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 10, 1055-1062. (Pubitemid 32959152)
30. Terry P, Lagergren J, Ye W, et al. (2000) Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 87, 750-754. (Pubitemid 30620420)
31. Tzonou A, Lipworth L, Garidou A, et al. (1996) Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer 68, 300-304. (Pubitemid 26384131)
32. Bollschweiler E, Wolfgarten E, Nowroth T, et al. (2002) Vitamin intake and risk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol 128, 575-580. (Pubitemid 35244934)
33. Kubo A, Corley DA (2007) Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol 102, 2323-2330. (Pubitemid 47493829)
34. Kabat GC, Ng SK, Wynder EL (1993) Tobacco, alcohol intake, and diet in relation to adenocarcinomaof the esophagus and gastric cardia. Cancer Causes Control 4, 123-132.
35. Brown LM, Swanson CA, Gridley G, et al. (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87, 104-109.
36. Zhang ZF, Kurtz RC, Yu GP, et al. (1997) Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 27, 298-309.
37. Kubo A, Levin TR, Block G, et al. (2007) Inverse associations between intake of antioxidants, fruits and vegetables and Barretts esophagus (abstract). Am J Epidemiol 165, S48.
38. Fountoulakis A, Martin IG, White KL, et al. (2004) Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barretts esophagus. Dig Dis Sci 49, 914-919. (Pubitemid 39012272)
39. Carman S, Kamangar F, Freedman ND, et al. (2009)VitaminE intake and risk of esophageal and gastric cancers in the NIHAARP Diet and Health Study. Int J Cancer 125, 165-170.
40. Steevens J, van den Brandt PA, Goldbohm RA, et al. (2010) Selenium status and the risk of esophageal and gastric cancer subtypes: The Netherlands Cohort Study. Gastroenterology 138, 1704-1713.
41. Moe GL, Kristal AR, Levine DS, et al. (2000) Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barretts esophagus. Nutr Cancer 36, 7-13.
42. Cheng KK, Sharp L, McKinney PA, et al. (2000) A case- control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 83, 127-132. (Pubitemid 30352729)
43. Dong LM, Kristal AR, Peters U, et al. (2008) Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer 60, 39-48. (Pubitemid 351186214)
44. Reid BJ, Prevo LJ, Galipeau PC, et al. (2001) Predictors of progression in Barretts esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 96, 2839-2848.
45. Barrett MT, Sanchez CA, Prevo LJ, et al. (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22, 106-109.
46. van Lieshout EM, Jansen JB, Peters WH (1998) Biomarkers in Barretts esophagus (review). Int J Oncol 13, 855-864.
47. Chun OK, Floegel A, Chung SJ, et al. (2009) Estimation of antioxidant intakes from diet and supplements in U.S. adults. J Nutr 140, 317-324.
48. International Agency for Research on Cancer (2006) Ingested Nitrates and Nitrites, and Some Cyanobacterial Peptide Toxins. Lyon, France: IARC.
49. Steinmetz KA, Potter JD (1991) Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 2, 427-442.
50. Mirvish SS, Wallcave L, Eagen M, et al. (1972) Ascorbate- nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science 177, 65-68.
51. Navarro Silvera SA, Mayne ST, Risch H, et al. (2008) Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer 123, 852-860. (Pubitemid 352032412)
52. Anderson LA, Watson RG, Murphy SJ, et al. (2007) Risk factors for Barretts oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 13, 1585-1594.
53. Engel LS, Chow WH, Vaughan TL, et al. (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95, 1404-1413. (Pubitemid 37220460)
54. Chen H, Ward MH, Graubard BI, et al. (2002) Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 75, 137-144. (Pubitemid 34008031)
55. Terry P, Terry JB, Wolk A (2001) Fruit and vegetable consumption in the prevention of cancer: an update. J Intern Med 250, 280-290. (Pubitemid 32955614)
56. Terry P, Lagergren J, Hansen H, et al. (2001) Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev 10, 365-369. (Pubitemid 32735353)
57. Freedman ND, Park Y, Subar AF, et al. (2007) Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer 121, 2753-2760. (Pubitemid 350136423)
58. Gonzalez CA, Pera G, Agudo A, et al. (2006) Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 118, 2559-2566. (Pubitemid 43338214)
59. Steinmetz KA, Potter JD (1996) Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96, 1027-1039.
60. Bobe G, Peterson JJ, Gridley G, et al. (2009) Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer 125, 1147-1154.
61. Thompson OM, Beresford SA, Kirk EA, et al. (2009) Vegetable and fruit intakes and risk of Barretts esophagus in men and women. Am J Clin Nutr 89, 890-896.
62. Kristal AR, Blount PL, Schenk JM, et al. (2005) Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Cancer Epidemiol Biomarkers Prev 14, 2377-2383.
63. Kubo A, Levin TR, Block G, et al. (2008) Dietary antioxidants, fruits, and vegetables and the risk of Barretts esophagus. Am J Gastroenterol 103, 1614-1624.
64. DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100, 190-200. (Pubitemid 41623288)
65. Thompson CL, Khiani V, Chak A, et al. (2008) Carbohydrate consumption and esophageal cancer:an ecological assessment. Am J Gastroenterol 103, 555-561. (Pubitemid 351405985)
66. Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115, 86-96.
67. Baserga R, Peruzzi F, Reiss K (2003) The IGF-1 receptor in cancer biology. Int J Cancer 107, 873-877. (Pubitemid 37429826)
68. Renehan AG, Zwahlen M, Minder C, et al. (2004) Insulinlike growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363, 1346-1353. (Pubitemid 38529873)
69. Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60, 91-106. (Pubitemid 32183103)
70. Tchorzewski MT, Qureshi FG, Duncan MD, et al. (1998) Role of insulin-like growth factor-I in esophageal mucosal healing processes. J Lab Clin Med 132, 134-141.
71. Chen K, Nezu R, Wasa M, et al. (1999) Insulin-like growth factor-1 modulation of intestinal epithelial cell restitution. JPEN J Parenter Enteral Nutr 23, Suppl. 5, S89-S92.
72. Korolkiewicz RP, Tashima K, Fujita A, et al. (2000) Exogenous insulin-like growth factor (IGF)-1 improves the impaired healing of gastric mucosal lesions in diabetic rats. Pharmacol Res 41, 221-229. (Pubitemid 30670338)
73. Steeb CB, Trahair JF, Tomas FM, et al. (1994) Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am J Physiol 266, G1090-G1098. (Pubitemid 2110834)
74. Hollowood AD, Lai T, Perks CM, et al. (2000) IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer 88, 336-341.
75. Mulholland HG, Cantwell MM, Anderson LA, et al. (2009) Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barretts esophagus, and esophageal adenocarcinoma. Cancer Causes Control 20, 279-288.
76. Wu AH, Tseng CC, Hankin J, et al. (2007) Fiber intake and risk of adenocarcinomas of the esophagus and stomach. Cancer Causes Control 18, 713-722. (Pubitemid 46988239)
77. Terry P, Lagergren J, YeW, et al. (2001) Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology 120, 387-391. (Pubitemid 32147636)
78. Kubo A, Block G, Quesenberry C, et al. (2009) Effects of dietary fiber, fats, and meat intakes on the risk of Barretts esophagus. Nutr Cancer 61, 607-616.
79. McFadden DW, Riggs DR, Jackson BJ, et al. (2008) Cornderived carbohydrate inositol hexaphosphate inhibits Barretts adenocarcinoma growth by pro-apoptotic mechanisms. Oncol Rep 19, 563-566.
80. Ma Y, Hebert JR, Li W, et al. (2008) Association between dietary fiber and markers of systemic inflammation in the Womens Health Initiative Observational Study. Nutrition 24, 941-949.
81. Burkitt DP (1981) The protective properties of dietary fiber. N C Med J 42, 467-471.
82. Sanjoaquin MA, Allen N, Couto E, et al. (2005) Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113, 825-828. (Pubitemid 40101266)
83. Kono S, Chen K (2005) Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci 96, 535-542. (Pubitemid 41488416)
84. Larsson SC, Giovannucci E & Wolk A (2006) Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131, 1271-1283.
85. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al. (2003) Esophageal and gastric cardia cancer risk and folate- and vitamin B12-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12, 1222-1226.
86. Balbuena L, Casson AG (2010) Dietary folate and vitamin B6 are not associated with p53 mutations in esophageal adenocarcinoma. Mol Carcinog 49, 211-214.
87. Duthie SJ (1999) Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55, 578-592.
88. Bailey LB (2003) Folate, methyl-related nutrients, alcohol, and the MTHFR 677C ! T polymorphism affect cancer risk: intake recommendations. J Nutr 133, Suppl. 1, 3748S-3753S.
89. Zheng W, Lee SA (2009) Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer 61, 437-446.
90. Norat T, Lukanova A, Ferrari P, et al. (2002) Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 98, 241-256. (Pubitemid 34150809)
91. Gonzalez CA, Jakszyn P, Pera G, et al. (2006) Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98, 345-354. (Pubitemid 43338214)
92. De Stefani E, Ronco A, Mendilaharsu M, et al. (1998) Case-control study on the role of heterocyclic amines in the etiology of upper aerodigestive cancers in Uruguay. Nutr Cancer 32, 43-48. (Pubitemid 28519242)
93. Terry PD, Lagergren J, Wolk A, et al. (2003) Dietary intake of heterocyclic amines and cancers of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev 12, 940-944. (Pubitemid 37151533)
94. Ward MH, Sinha R, Heineman EF, et al. (1997) Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 71, 14-19. (Pubitemid 27158403)
95. Jakszyn P, Gonzalez CA (2006) Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 12, 4296-4303. (Pubitemid 44194520)
96. Lijinsky W & Kovatch RM (1985) Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis 6, 1679-1681. (Pubitemid 16168974)
97. Ivankovic S, Seibel J, Komitowski D, et al. (1998) Caffeinederived N-nitroso compounds. V. Carcinogenicity of mononitrosocaffeidine and dinitrosocaffeidine in bd-ix rats. Carcinogenesis 19, 933-937. (Pubitemid 28376789)
98. Preussmann R, Habs M, Habs H, et al. (1983) Fluorosubstituted N-nitrosamines. 6. Carcinogenicity of N-nitroso- (2,2,2-trifluoroethyl)- ethylamine in rats. Carcinogenesis 4, 755-757. (Pubitemid 13028136)
99. Ward MH, Heineman EF, Markin RS, et al. (2008) Adenocarcinoma of the stomach and esophagus and drinking water and dietary sources of nitrate and nitrite. Int J Occup Environ Health 14, 193-197.
100. Clark GW, Smyrk TC, Mirvish SS, et al. (1994) Effect of gastroduodenal juice and dietary fat on the development of Barretts esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1, 252-261.
101. Chen KH, Mukaisho K, Sugihara H, et al. (2007) High animal-fat intake changes the bile-acid composition of bile juice and enhances the development of Barretts esophagus and esophageal adenocarcinoma in a rat duodenal-contents reflux model. Cancer Sci 98, 1683-1688. (Pubitemid 47487901)
102. Terry P, Lagergren J, Wolk A, et al. (2000) Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer 38, 186-191. (Pubitemid 32762018)
103. Mozaffarian D, Pischon T, Hankinson SE, et al. (2004) Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79, 606-612. (Pubitemid 41103904)
104. Tselepis C, Perry I, Dawson C, et al. (2002) Tumour necrosis factor - a in Barretts oesophagus: a potential novel mechanism of action. Oncogene 21, 6071-6081.
105. Mehta SP, Boddy AP, Cook J, et al. (2008) Effect of n-3 polyunsaturated fatty acids on Barretts epithelium in the human lower esophagus. Am J Clin Nutr 87, 949-956. (Pubitemid 351549240)
106. Wilson KT, Fu S, Ramanujam KS, et al. (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase- 2 in Barretts esophagus and associated adenocarcinomas. Cancer Res 58, 2929-2934. (Pubitemid 28335064)
107. Liu XH, Yao S, Kirschenbaum A, et al. (1998) NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 58, 4245-4249. (Pubitemid 28450018)
108. Kubo A, Levin TR, Block G, et al. (2008) Dietary patterns and the risk of Barretts esophagus. Am J Epidemiol 167, 839-846. (Pubitemid 351451748)
109. Bahmanyar S, Ye W (2006) Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden. Nutr Cancer 54, 171-178. (Pubitemid 44316299)
110. Hamoui N, Lord RV, Hagen JA, et al. (2006) Response of the lower esophageal sphincter to gastric distention by carbonated beverages. J Gastrointest Surg 10, 870-877. (Pubitemid 43850374)
111. Lagergren J, Viklund P, Jansson C (2006) Carbonated soft drinks and risk of esophageal adenocarcinoma: a population- based case-control study. J Natl Cancer Inst 98, 1158-1161. (Pubitemid 44288790)
112. Ibiebele TI, Hughes MC, ORourke P, et al. (2008) Cancers of the esophagus and carbonated beverage consumption: a population-based case-control study. Cancer Causes Control 19, 577-584.
113. Mayne ST, Risch HA, Dubrow R, et al. (2006) Carbonated soft drink consumption and risk of esophageal adenocarcinoma. J Natl Cancer Inst 98, 72-75. (Pubitemid 43057095)
114. Chen X, Yang G, Ding WY, et al. (1999) An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 20, 1801-1808. (Pubitemid 29410561)
115. Barton JC, Acton RT, Dawkins FW, et al. (2005) Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 9, 231-241.
116. McClung JP, Marchitelli LJ, Friedl KE, et al. (2006) Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr 25, 64-69.
117. Beutler E, West C (2005) Hematologic differences between African-Americans and whites: the roles of iron deficiency and a-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 106, 740-745. (Pubitemid 40981275)
118. Corley DA, Kubo A, Levin TR, et al. (2008) Iron intake and body iron stores as risk factors for Barretts esophagus: a community-based study. Am J Gastroenterol 103, 2997-3004.
119. National Research Council Committee on Diet and Health (1989) Diet and Health. Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press.